Back
Altimmune Vs. Amgen Industry Stock Comparison
Buy
56
ALT
Altimmune
Last Price:
7.57
Seasonality Move:
0.83%
Buy
54
AMGN
Amgen
Last Price:
336.06
Seasonality Move:
5.51%
Buy
56
Altimmune (ALT)
is a Buy
Is Altimmune a Buy, Sell or Hold?
- The current Altimmune [ALT] share price is $7.58. The Score for ALT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ALT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Amgen (AMGN)
is a Buy
Is Amgen a Buy, Sell or Hold?
- The current Amgen [AMGN] share price is $335.95. The Score for AMGN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- AMGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMGN Stock Price Chart
ALT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.26 | Buy |
Relative Strength Index (14 RSI): | 60.38 | Buy |
Chaikin Money Flow: | -1230729 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.43 - 7.37) | Buy |
Bollinger Bands (100): | (6.23 - 7.55) | Buy |
AMGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2 | Buy |
Relative Strength Index (14 RSI): | 59.49 | Buy |
Chaikin Money Flow: | -535615 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (325.2 - 332.78) | Buy |
Bollinger Bands (100): | (303.43 - 331.83) | Buy |
ALT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.41 | Buy |
20-day SMA: | 6.91 | Buy |
50-day SMA: | 6.73 | Buy |
200-day SMA: | 8.1 | Sell |
8-day EMA: | 7.35 | Buy |
20-day EMA: | 7.03 | Buy |
50-day EMA: | 6.87 | Buy |
200-day EMA: | 7.1 | Buy |
AMGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 332.28 | Buy |
20-day SMA: | 329.61 | Buy |
50-day SMA: | 329.27 | Buy |
200-day SMA: | 301.43 | Buy |
8-day EMA: | 332.47 | Buy |
20-day EMA: | 330.19 | Buy |
50-day EMA: | 325.93 | Buy |
200-day EMA: | 302.97 | Buy |
Altimmune Earnings Growth & ALT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.66 per share, and a decrease next year of $0.29 per share.
Amgen Earnings Growth & AMGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.41 per share, an increase this year of $0.98 per share, and an increase next year of $1.23 per share.
Altimmune Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amgen Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |